AstraZeneca's newly-announced ambitions point to big growth ahead. At the same time, Pfizer's strategy is also proving quite ambitious. AstraZeneca isn't planning on doing as much business development ...

LONDON (Reuters) - On a sunny day in San Francisco last January, AstraZeneca Chief Executive Pascal Soriot was on his way to the Westin St. Francis hotel on Union Square to give investors some ...

Pfizer (NYSE: PFE) and AstraZeneca (NYSE: AZN) had returned to the negotiating table, with a sweetened offer for the British drug maker, according to a story by The Wall Street Journal. But ...

An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014. The board of pharmaceutical company AstraZeneca ...

Pfizer, which on Monday acquired cancer drugmaker Medivation for $14 billion, has added to its portfolio yet again. The New York-based drugmaker will buy AstraZeneca’s small molecule antibiotics ...

WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White House as he announces a deal with Pfizer to lower drug prices on September 30, ...

Leading vaccine makers like Eli Lilly and Co. (NYSE: LLY), Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic, but now ...

(Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's ...

PARIS — Health care companies Pfizer and AstraZeneca announced Sunday new investment in France worth a total of nearly $1 billion. Pfizer said it plans to invest $538.5 million in France to build its ...

A Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc (NYSE:PFE) $107.5 million in damages, concluding that AstraZeneca’s blockbuster lung cancer drug, Tagrisso, ...